The TWEAK-Fn14 Cytokine-receptor Axis: Discovery, Biology and Therapeutic Targeting

Overview

Journal Nat Rev Drug Discov

Specialty Pharmacology

Date 2008 Apr 12

PMID 18404150

Citations 274

Authors

Jeffrey A Winkles

Affiliations

Soon will be listed here.

Abstract

TWEAK is a multifunctional cytokine that controls many cellular activities including proliferation, migration, differentiation, apoptosis, angiogenesis and inflammation. TWEAK acts by binding to Fn14, a highly inducible cell-surface receptor that is linked to several intracellular signalling pathways, including the nuclear factor-kappaB (NF-kappaB) pathway. The TWEAK-Fn14 axis normally regulates various physiological processes, in particular it seems to play an important, beneficial role in tissue repair following acute injury. Furthermore, recent studies have indicated that TWEAK-Fn14 axis signalling may contribute to cancer, chronic autoimmune diseases and acute ischaemic stroke. This Review provides an overview of TWEAK-Fn14 axis biology and summarizes the available data supporting the proposal that both TWEAK and Fn14 should be considered as potential targets for the development of novel therapeutics.

Citing Articles

Molecular differences between young and mature stria vascularis from organotypic explants and transcriptomics.

Thulasiram M, Yamamoto R, Olszewski R, Gu S, Morell R, Hoa M iScience. 2025; 28(2):111832.

PMID: 40028281 PMC: 11869990. DOI: 10.1016/j.isci.2025.111832.

Investigating the role of inflammatory cytokines in mediating the effect of gut microbiota on gastrointestinal cancers: a mendelian randomization study.

Liu W, Hu X, Choy Y, Lai W, Xu H, Zeng Y Gastric Cancer. 2025; .

PMID: 39961989 DOI: 10.1007/s10120-025-01587-w.

Immune profiling of human vestibular schwannoma secretions identifies TNF-α and TWEAK as cytokines with synergistic potential to impair hearing.

Vasilijic S, Seist R, Yin Z, Xu L, Stankovic K J Neuroinflammation. 2025; 22(1):35.

PMID: 39923035 PMC: 11807327. DOI: 10.1186/s12974-025-03364-z.

Exosomes derived from FN14-overexpressing BMSCs activate the NF-κB signaling pathway to induce PANoptosis in osteosarcoma.

Wang L, Huang Y, Zhang X, Chen W, Dai Z Apoptosis. 2025; .

PMID: 39833632 DOI: 10.1007/s10495-024-02071-z.

Fibroblast growth factor-inducible 14 regulates satellite cell self-renewal and expansion during skeletal muscle repair.

Tomaz da Silva M, Joshi A, Kumar A bioRxiv. 2025; .

PMID: 39803454 PMC: 11722277. DOI: 10.1101/2024.10.06.616900.

References

Foster D, Parrish-Novak J, Fox B, Xu W . Cytokine-receptor pairing: accelerating discovery of cytokine function. Nat Rev Drug Discov. 2004; 3(2):160-70. DOI: 10.1038/nrd1305. View

Almstrup K, Hoei-Hansen C, Wirkner U, Blake J, Schwager C, Ansorge W . Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res. 2004; 64(14):4736-43. DOI: 10.1158/0008-5472.CAN-04-0679. View

Tran N, McDonough W, Donohue P, Winkles J, Berens T, Ross K . The human Fn14 receptor gene is up-regulated in migrating glioma cells in vitro and overexpressed in advanced glial tumors. Am J Pathol. 2003; 162(4):1313-21. PMC: 1851233. DOI: 10.1016/S0002-9440(10)63927-2. View

Dirnagl U, Iadecola C, Moskowitz M . Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999; 22(9):391-7. DOI: 10.1016/s0166-2236(99)01401-0. View

Wiley S, Winkles J . TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev. 2003; 14(3-4):241-9. DOI: 10.1016/s1359-6101(03)00019-4. View

Marsters S, Sheridan J, Pitti R, Brush J, Goddard A, Ashkenazi A . Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol. 1998; 8(9):525-8. DOI: 10.1016/s0960-9822(98)70204-0. View

Schneider P, Schwenzer R, Haas E, Muhlenbeck F, Schubert G, Scheurich P . TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol. 1999; 29(6):1785-92. DOI: 10.1002/(SICI)1521-4141(199906)29:06<1785::AID-IMMU1785>3.0.CO;2-U. View

Watts G, Tran N, Berens M, Bhattacharyya A, Nelson M, Montgomery E . Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma. Int J Cancer. 2007; 121(10):2132-9. DOI: 10.1002/ijc.22898. View

Justo P, Sanz A, Sanchez-Nino M, Winkles J, Lorz C, Egido J . Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int. 2006; 70(10):1750-8. DOI: 10.1038/sj.ki.5001866. View

10.

Kim S, Kang Y, Kim W, Woo D, Lee Y, Kim D . TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages. Circ J. 2004; 68(4):396-9. DOI: 10.1253/circj.68.396. View

11.

Peter M, Krammer P . The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003; 10(1):26-35. DOI: 10.1038/sj.cdd.4401186. View

12.

Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H . Multiple pathways of TWEAK-induced cell death. J Immunol. 2002; 168(2):734-43. DOI: 10.4049/jimmunol.168.2.734. View

13.

Kawakita T, Shiraki K, Yamanaka Y, Yamaguchi Y, Saitou Y, Enokimura N . Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis. Biochem Biophys Res Commun. 2004; 318(3):726-33. DOI: 10.1016/j.bbrc.2004.04.084. View

14.

Munoz-Garcia B, Martin-Ventura J, Martinez E, Sanchez S, Hernandez G, Ortega L . Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin. Stroke. 2006; 37(8):2044-53. DOI: 10.1161/01.STR.0000230648.00027.00. View

15.

Campbell S, Burkly L, Gao H, Berman J, Su L, Browning B . Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol. 2006; 176(3):1889-98. DOI: 10.4049/jimmunol.176.3.1889. View

16.

Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K . Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol. 2002; 170(1):341-8. DOI: 10.4049/jimmunol.170.1.341. View

17.

Tanabe K, Bonilla I, Winkles J, Strittmatter S . Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci. 2003; 23(29):9675-86. PMC: 6740475. View

18.

Nakayama M, Harada N, Okumura K, Yagita H . Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies. Biochem Biophys Res Commun. 2003; 306(4):819-25. DOI: 10.1016/s0006-291x(03)01051-9. View

19.

Chacon M, Richart C, Gomez J, Megia A, Vilarrasa N, Fernandez-Real J . Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity. Cytokine. 2006; 33(3):129-37. DOI: 10.1016/j.cyto.2005.12.005. View

20.

Jakubowski A, Ambrose C, Parr M, Lincecum J, Wang M, Zheng T . TWEAK induces liver progenitor cell proliferation. J Clin Invest. 2005; 115(9):2330-40. PMC: 1187931. DOI: 10.1172/JCI23486. View